vs
Side-by-side financial comparison of JAKKS PACIFIC INC (JAKK) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
JAKKS PACIFIC INC is the larger business by last-quarter revenue ($106.7M vs $75.5M, roughly 1.4× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -5.8%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -15.3%).
Jakks Pacific, Inc. is an American toy manufacturer founded in January 1995. The company is best known for producing licensed action figures, playsets, dolls, plush toys and dress-up sets. They are also well known for their line up of Plug-n-Play Television Game Consoles popularized in the 2000s.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
JAKK vs PBYI — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $106.7M | $75.5M |
| Net Profit | $80.0K | — |
| Gross Margin | 33.4% | 69.3% |
| Operating Margin | — | 22.7% |
| Net Margin | 0.1% | — |
| Revenue YoY | -5.8% | 27.7% |
| Net Profit YoY | — | — |
| EPS (diluted) | — | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $106.7M | — | ||
| Q4 25 | $127.1M | $75.5M | ||
| Q3 25 | $211.2M | $54.5M | ||
| Q2 25 | $119.1M | $52.4M | ||
| Q1 25 | $113.3M | $46.0M | ||
| Q4 24 | $130.7M | $59.1M | ||
| Q3 24 | $321.6M | $80.5M | ||
| Q2 24 | $148.6M | $47.1M |
| Q1 26 | $80.0K | — | ||
| Q4 25 | $-5.3M | — | ||
| Q3 25 | $19.9M | $8.8M | ||
| Q2 25 | $-2.3M | $5.9M | ||
| Q1 25 | $-2.4M | $3.0M | ||
| Q4 24 | $-9.1M | — | ||
| Q3 24 | $52.3M | $20.3M | ||
| Q2 24 | $5.3M | $-4.5M |
| Q1 26 | 33.4% | — | ||
| Q4 25 | 31.0% | 69.3% | ||
| Q3 25 | 32.0% | 77.7% | ||
| Q2 25 | 32.8% | 76.5% | ||
| Q1 25 | 34.4% | 77.1% | ||
| Q4 24 | 27.2% | 76.4% | ||
| Q3 24 | 33.8% | 63.9% | ||
| Q2 24 | 32.0% | 77.4% |
| Q1 26 | — | — | ||
| Q4 25 | -6.8% | 22.7% | ||
| Q3 25 | 13.9% | 17.6% | ||
| Q2 25 | -2.3% | 12.7% | ||
| Q1 25 | -3.3% | 8.7% | ||
| Q4 24 | -11.3% | 22.6% | ||
| Q3 24 | 21.2% | 27.4% | ||
| Q2 24 | 5.1% | -4.6% |
| Q1 26 | 0.1% | — | ||
| Q4 25 | -4.2% | — | ||
| Q3 25 | 9.4% | 16.2% | ||
| Q2 25 | -1.9% | 11.2% | ||
| Q1 25 | -2.1% | 6.5% | ||
| Q4 24 | -7.0% | — | ||
| Q3 24 | 16.3% | 25.2% | ||
| Q2 24 | 3.5% | -9.6% |
| Q1 26 | — | — | ||
| Q4 25 | $-0.46 | $0.26 | ||
| Q3 25 | $1.74 | $0.17 | ||
| Q2 25 | $-0.21 | $0.12 | ||
| Q1 25 | $-0.21 | $0.06 | ||
| Q4 24 | $-0.70 | $0.40 | ||
| Q3 24 | $4.64 | $0.41 | ||
| Q2 24 | $0.47 | $-0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $62.8M | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $242.0M | $130.3M |
| Total Assets | $400.4M | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $62.8M | — | ||
| Q4 25 | $52.2M | $97.5M | ||
| Q3 25 | $25.9M | $94.4M | ||
| Q2 25 | $38.2M | $96.0M | ||
| Q1 25 | $59.2M | $93.2M | ||
| Q4 24 | $69.9M | $101.0M | ||
| Q3 24 | $22.1M | $96.7M | ||
| Q2 24 | $17.7M | $96.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M |
| Q1 26 | $242.0M | — | ||
| Q4 25 | $249.1M | $130.3M | ||
| Q3 25 | $255.9M | $115.3M | ||
| Q2 25 | $236.2M | $104.7M | ||
| Q1 25 | $234.5M | $97.1M | ||
| Q4 24 | $240.3M | $92.1M | ||
| Q3 24 | $249.6M | $71.1M | ||
| Q2 24 | $195.4M | $48.5M |
| Q1 26 | $400.4M | — | ||
| Q4 25 | $442.2M | $216.3M | ||
| Q3 25 | $485.3M | $202.9M | ||
| Q2 25 | $438.7M | $194.9M | ||
| Q1 25 | $405.9M | $196.2M | ||
| Q4 24 | $444.9M | $213.3M | ||
| Q3 24 | $523.9M | $220.7M | ||
| Q2 24 | $378.3M | $205.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $14.4M |
| Free Cash FlowOCF − Capex | — | $14.4M |
| FCF MarginFCF / Revenue | — | 19.1% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $33.2M | $14.4M | ||
| Q3 25 | $-8.8M | $9.7M | ||
| Q2 25 | $-14.2M | $14.1M | ||
| Q1 25 | $-1.7M | $3.6M | ||
| Q4 24 | $54.1M | $15.6M | ||
| Q3 24 | $12.5M | $11.0M | ||
| Q2 24 | $-14.8M | $1.0M |
| Q1 26 | — | — | ||
| Q4 25 | $31.5M | $14.4M | ||
| Q3 25 | $-12.2M | $9.7M | ||
| Q2 25 | $-16.6M | $14.1M | ||
| Q1 25 | $-3.8M | $3.6M | ||
| Q4 24 | $50.2M | $15.6M | ||
| Q3 24 | $9.8M | $11.0M | ||
| Q2 24 | $-17.2M | $1.0M |
| Q1 26 | — | — | ||
| Q4 25 | 24.8% | 19.1% | ||
| Q3 25 | -5.8% | 17.7% | ||
| Q2 25 | -14.0% | 26.8% | ||
| Q1 25 | -3.3% | 7.7% | ||
| Q4 24 | 38.4% | 26.4% | ||
| Q3 24 | 3.0% | 13.7% | ||
| Q2 24 | -11.6% | 2.1% |
| Q1 26 | — | — | ||
| Q4 25 | 1.3% | 0.0% | ||
| Q3 25 | 1.6% | 0.0% | ||
| Q2 25 | 2.0% | 0.0% | ||
| Q1 25 | 1.8% | 0.1% | ||
| Q4 24 | 3.0% | 0.0% | ||
| Q3 24 | 0.8% | 0.0% | ||
| Q2 24 | 1.6% | 0.0% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | -0.44× | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.24× | 0.54× | ||
| Q2 24 | -2.81× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
JAKK
| United States | $74.6M | 70% |
| Europe | $17.4M | 16% |
| Latin America | $7.0M | 7% |
| Canada | $3.0M | 3% |
| Australia & New Zealand | $2.5M | 2% |
| Other | $2.2M | 2% |
PBYI
Segment breakdown not available.
